Table 2.4.
Criteria for screening for diabetes or prediabetes in asymptomatic adults
| 1. Testing should be considered in adults with overweight or obesity (BMI ≥25 kg/m2 or ≥23 kg/m2 in Asian American individuals) who have one or more of the following risk factors: |
| • First-degree relative with diabetes |
| • High-risk race and ethnicity (e.g., African American, Latino, Native American, Asian American, Pacific Islander) |
| • History of cardiovascular disease |
| • Hypertension (≥130/80 mmHg or on therapy for hypertension) |
| • HDL cholesterol level <35 mg/dL (<0.9 mmol/L) and/or a triglyceride level >250 mg/dL (>2.8 mmol/L) |
| • Individuals with polycystic ovary syndrome |
| • Physical inactivity |
| • Other clinical conditions associated with insulin resistance (e.g., severe obesity, acanthosis nigricans) |
| 2. People with prediabetes (A1C ≥5.7% [≥39 mmol/mol], IGT, or IFG) should be tested yearly. |
| 3. People who were diagnosed with GDM should have lifelong testing at least every 3 years. |
| 4. For all other people, testing should begin at age 35 years. |
| 5. If results are normal, testing should be repeated at a minimum of 3-year intervals, with consideration of more frequent testing depending on initial results and risk status. |
| 6. People with HIV, exposure to high-risk medicines, history of pancreatitis |
GDM, gestational diabetes mellitus; IFG, impaired fasting glucose; IGT, impaired glucose tolerance.